Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

September 05, 2018

Correspondence
Revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment
Free

Sylvia Broeders, Sylvie Goletti, Jean-Paul Tomasi, Carolien Bonroy, René-Louis Humbel, Laurence Lutteri, Sofie Schouwers, Lieve Van Hoovels, Martine Vercammen, Xavier Bossuyt

doi: 10.1136/annrheumdis-2018-214078
Letter
Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer’s disease: a population-based cohort study

Laurence Fardet, Irwin Nazareth, Irene Petersen

doi: 10.1136/annrheumdis-2018-214016

August 29, 2018

Letter
How to reduce the waiting time for the first consultation with the rheumatologist as a first step for a timely treatment

Omar Valenzuela, Sebastián E Ibáñez Vodnizza

doi: 10.1136/annrheumdis-2018-213793

August 27, 2018

Correspondence
Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis
Free

Emily J Liebling, Rosemary Peterson, Teresa Victoria, Jon M Burnham

doi: 10.1136/annrheumdis-2018-214191

August 20, 2018

Correspondence response
Response to: ’Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis' by Ferreira et al

Robert B M Landewé

doi: 10.1136/annrheumdis-2018-214221
Correspondence
Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis

Ricardo J O Ferreira, Mwidimi Ndosi, Maarten de Wit, Eduardo José Ferreira Santos, Cátia Duarte, Johannes W G Jacobs, Pedro M Machado, Désirée van der Heijde, Laure Gossec, Jose A P da Silva

doi: 10.1136/annrheumdis-2018-214199

August 17, 2018

Correspondence response
Response to ’Response to viewpoint ’Defining refractory rheumatoid arthritis' by Buch' by Roodenrijs et al

Maya H Buch

doi: 10.1136/annrheumdis-2018-214153

August 14, 2018

Correspondence
Digital health in rheumatology

Vinod Ravindran, Suchitra Kataria

doi: 10.1136/annrheumdis-2018-214146

August 12, 2018

Correspondence response
Response to: ‘Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimated’ by Moiseev et al

Liang Wu, Min Chen

doi: 10.1136/annrheumdis-2018-214145
Correspondence response
Response to: ‘Checkpoint inhibitors and arthritis: seeking balance between victories and defeats’ by Moura and Moura

Thierry Schaeverbeke, Marie Kostine

doi: 10.1136/annrheumdis-2018-213906

August 10, 2018

Correspondence response
Response to: ’Early identification of rheumatoid arthritis; the risk of overtreatment in perspective' by Landewé

Robert B M Landewé

doi: 10.1136/annrheumdis-2018-214172
Correspondence
Early identification of rheumatoid arthritis: the risk of overtreatment in perspective

Annette van der Helm-van Mil

doi: 10.1136/annrheumdis-2018-214156

July 30, 2018

Correspondence
Response to viewpoint ‘Defining refractory rheumatoid arthritis’ by Buch

Nadia MT Roodenrijs, Maria JH de Hair, Marlies C van der Goes, Johannes WG Jacobs

doi: 10.1136/annrheumdis-2018-214147
Correspondence
Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimated

Nikolai Bulanov, Natalia V Chebotareva, Pavel I Novikov, Sergey V Moiseev

doi: 10.1136/annrheumdis-2018-214095

July 27, 2018

Correspondence response
Response to: ‘Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors’ by Delyon et al

Marie Kostine, Thierry Schaeverbeke on behalf of the FHU-ACRONIM

doi: 10.1136/annrheumdis-2018-213895

July 21, 2018

Correspondence response
Response to: ‘Can we further SPARkle the SPAR model?’ by Kavadichanda et al

Wanlong Wu, Suzana Jordan, Oliver Distler

doi: 10.1136/annrheumdis-2018-213962

July 20, 2018

Correspondence
Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands?

Gaetane Nocturne, Raphaele Seror, Xavier Mariette

doi: 10.1136/annrheumdis-2018-213979
Correspondence response
Response to: ‘Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands?’ by Nocturne et al

Efstathia K Kapsogeorgou, Aristea Papageorgiou, Athanase D Protogerou, Michael Voulgarelis, Athanasios G Tzioufas

doi: 10.1136/annrheumdis-2018-214009

July 12, 2018

Correspondence response
Response to: ‘The use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?’ by Wu et al

Lennart Jans, Isabelle De Kock, Nele Herregods, Koenraad L Verstraete, Filip E Van den Bosch, Philippe Carron, Edwin H Oei, Dirk Elewaut, Peggy Jacques

doi: 10.1136/annrheumdis-2018-213960
Correspondence
Use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?

Haijun Wu, Guangfeng Zhang, Xiaoyu Huang, Changhong Liang

doi: 10.1136/annrheumdis-2018-213892

July 10, 2018

Correspondence response
Response to: ‘Inconsistency between supplement and article?’ by Babaoglu H

Désirée van der Heijde, Natasha de Peyrecave, Tommi Nurminen

doi: 10.1136/annrheumdis-2018-213887

June 29, 2018

Correspondence
Variation in antinuclear antibody detection: need for clear expectations and additional studies

Michael Mahler, Carolina Auza

doi: 10.1136/annrheumdis-2018-213888
Correspondence
Can we further SPARkle the SPAR model?

Chengappa G Kavadichanda, Vir Singh Negi

doi: 10.1136/annrheumdis-2018-213954

June 27, 2018

Correspondence response
Response to: ‘Infrapatellar fat pad resection during total knee replacement: yet another reason?’ by Ryan

Zhaohua Zhu, Weiyu Han, Guangfeng Ruan, Shuang Zheng, Changhai Ding

doi: 10.1136/annrheumdis-2018-213701
Correspondence
Checkpoint inhibitors and arthritis: seeking balance between victories and defeats

Carlos Antonio Moura, Carlos Geraldo Moura

doi: 10.1136/annrheumdis-2018-213866

June 26, 2018

Correspondence
Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus

Fan Wang, Wei Zhang, Shiying Wang, Wenyou Pan, Lin Liu, Min Wu, Fuwan Ding, Huaixia Hu, Xiang Ding, Hua Wei, Yaohong Zou, Xian Qian, Meimei Wang, Jian Wu, Juan Tao, Jun Tan, Zhanyun Da, Miaojia Zhang, Jing Li, Xuebing Feng, Lingyun Sun

doi: 10.1136/annrheumdis-2018-213819
Correspondence response
Response to: ’Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus' by Wang et al

Nadine Müller-Calleja, Karl J Lackner

doi: 10.1136/annrheumdis-2018-213853

June 23, 2018

Correspondence response
Response to: ‘Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities’ by Bossuyt et al

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

doi: 10.1136/annrheumdis-2018-213841
Correspondence
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors

Anissa Roger, Matthieu Groh, Gwenael Lorillon, Claire Le Pendu, Jeremy Maillet, Dimitri Arangalage, Abdellatif Tazi, Celeste Lebbe, Barouyr Baroudjian, Julie Delyon the PATIO group

doi: 10.1136/annrheumdis-2018-213857
Correspondence
Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities

Philippe Willems, Ellen De Langhe, René Westhovens, Steven Vanderschueren, Daniel Blockmans, Xavier Bossuyt

doi: 10.1136/annrheumdis-2018-213821

June 22, 2018

Correspondence response
Response to: ‘Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1’ by Michot et al

Marie Kostine, Christophe Richez, Thierry Schaeverbeke on behalf of the FHU- ACRONIM

doi: 10.1136/annrheumdis-2018-213691

June 20, 2018

Correspondence response
Response to: ’Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass

Marie Kostine, Léa Dousset, Thierry Schaeverbeke on behalf of the FHU-ACRONIM

doi: 10.1136/annrheumdis-2018-213682
Correspondence
Treatment of hip osteoarthritis with glucocorticoids

Jian Zhou, Biao Liu, Chenxi Li, Yingquan Luo, Tang Liu, Wanchun Wang

doi: 10.1136/annrheumdis-2018-213871

June 19, 2018

Correspondence
Rituximab in ANCA-associated vasculitis: fewer infusions or ultra low-dose maintenance therapy?

Sergey V Moiseev, Nikolai M Bulanov, Anastasiia S Zykova, Pavel I Novikov

doi: 10.1136/annrheumdis-2018-213873
Editorial
Time to change the primary outcome of lupus trials
Free

Frederic A Houssiau

doi: 10.1136/annrheumdis-2018-213788
Correspondence
Inconsistency between supplement and article?

Hakan Babaoglu

doi: 10.1136/annrheumdis-2018-213844

June 16, 2018

Correspondence response
Response to: ‘Association between use of non-steroidal anti-inflammatory drugs and risk of myocardial infarction in patients with spondyloarthritis and osteoarthritis’

Maureen Dubreuil, Qiong Louie-Gao, Christine Peloquin, Hyon K Choi, Yuqing Zhang, Tuhina Neogi

doi: 10.1136/annrheumdis-2018-213771

June 06, 2018

Correspondence
Serum complement factor C5a in IgG₄-related disease

Shoichi Fukui, Yuya Fujita, Tomoki Origuchi, Takahiro Maeda, Atsushi Kawakami

doi: 10.1136/annrheumdis-2018-213705
Correspondence response
Response to: ‘Serum complement factor C5a in IgG4-related disease’ by Fukui et al

Hisanori Umehara, Mitsuhiro Kawano

doi: 10.1136/annrheumdis-2018-213729

June 01, 2018

Correspondence
Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1

Jean-Marie Michot, Mathilde Fusellier, Stephane Champiat, Charles Velter, Capucine Baldini, Anne-Laure Voisin, Francois-Xavier Danlos, Yolla El Dakdouki, Maxime Annereau, Xavier Mariette, Caroline Robert, Khadija Cherif, Aurélien Marabelle, Christine Mateus, Olivier Lambotte

doi: 10.1136/annrheumdis-2018-213677
Correspondence response
Response to: ’Not all drugs (and routes) are same' by Zanwar and Gandhi

Pierre Charles, Loic Guillevin

doi: 10.1136/annrheumdis-2018-213742
Correspondence
Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou et al: mutations in TRNT1 result in a constitutive activation of type I interferon signalling

Marie-Louise Frémond, Isabelle Melki, Sven Kracker, Vincent Bondet, Darragh Duffy, Gillian I Rice, Yanick J Crow, Brigitte Bader-Meunier

doi: 10.1136/annrheumdis-2018-213745
Correspondence
‘Not all drugs (and route) are same’

Abhishek Arvind Zanwar

doi: 10.1136/annrheumdis-2018-213730

May 31, 2018

Correspondence
Multimodal analgesia to reduce NSAID induced myocardial Infarction

Leigh White, Gun Hee An, Ruan Vlok

doi: 10.1136/annrheumdis-2018-213732
Correspondence
Are the loading dose treatment groups superior to the 150 mg without loading dose group in the secukinumab FUTURE 5 study?

Bernardo Matos da Cunha

doi: 10.1136/annrheumdis-2018-213770
Correspondence response
Response to ‘A missing pebble in the mosaic of rheumatic diseases and mental health: younger does not always mean happier’ by Alunno et al

Imke Redeker, Falk Hoffmann, Johanna Callhoff, Hildrun Haibel, Joachim Sieper, Angela Zink, Denis Poddubnyy

doi: 10.1136/annrheumdis-2018-213620
Correspondence
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: time to focus on

Pietro Enea Lazzerini, Franco Laghi Pasini, Maurizio Acampa, Pier Leopoldo Capecchi

doi: 10.1136/annrheumdis-2018-213789

May 25, 2018

Correspondence
Association between use of non-steroidal anti-inflammatory drugs and risk of myocardial infarction in patients with spondyloarthritis and osteoarthritis

Jian Zhou, Ying Xiao, Chenxi Li, Tang Liu, Wanchun Wang

doi: 10.1136/annrheumdis-2018-213752

May 18, 2018

Correspondence response
Response to: ’To DAPSA or not to DAPSA? That is not the question' by Schoels et al

Leonieke J J van Mens, Marleen G H van de Sande, Arno W R van Kuijk, Dominique L P Baeten, Laura C Coates

doi: 10.1136/annrheumdis-2018-213618

May 15, 2018

Correspondence
Infrapatellar fat pad resection during total knee arthroplasty: yet another reason for?

Thomas J Ryan

doi: 10.1136/annrheumdis-2018-213684

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

September 05, 2018

August 29, 2018

August 27, 2018

August 20, 2018

August 17, 2018

August 14, 2018

August 12, 2018

August 10, 2018

July 30, 2018

July 27, 2018

July 21, 2018

July 20, 2018

July 12, 2018

July 10, 2018

June 29, 2018

June 27, 2018

June 26, 2018

June 23, 2018

June 22, 2018

June 20, 2018

June 19, 2018

June 16, 2018

June 06, 2018

June 01, 2018

May 31, 2018

May 25, 2018

May 18, 2018

May 15, 2018

Pages